Essais liés3clinical trials
VilleSeattlelocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT04396574

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
Lasmiditan Migraine Phase 3 NCT04396574 PIONEER-PEDS2 — A 12-Month Study of Lasmiditan (LY573144) Treatment in Children Aged 6 to 17 With Migraine TERMINATED
Rimegepant Migraine Phase 3 NCT03461757 Trial in Adult Subjects With Acute Migraines COMPLETED
ALD403 Migraine Phase 1 NCT01772524 Safety, Efficacy and Pharmacokinetics of ALD403 COMPLETED